InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Michael R Megna, CHIEF ACCOUNTING OFFICER, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 12 open-market SEC Form 4 transactions: 0 purchases worth $0 and 12 sales worth $4.5M, reported from Dec 19, 23 to Oct 20, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 20, 25 | KNSAKiniksa Pharmaceuticals International, plc | SELL | 37.3K | $39.31 | $1.4M |
| Sep 3, 25 | KNSAKiniksa Pharmaceuticals International, plc | SELL | 11.0K | $34.84 | $383K |
| Aug 4, 25 | KNSAKiniksa Pharmaceuticals International, plc | SELL | 17.0K | $32.35 | $550K |
| Jun 3, 25 | KNSAKiniksa Pharmaceuticals International, plc | SELL | 15.2K | $28.75 | $437K |
| May 7, 25 | KNSAKiniksa Pharmaceuticals International, plc | SELL | 17.6K | $26.69 | $471K |
| Mar 12, 25 | KNSAKiniksa Pharmaceuticals International, plc | SELL | 9.1K | $22.45 | $203K |
| Nov 29, 24 | KNSAKiniksa Pharmaceuticals International, plc | SELL | 9 | $22.45 | $202 |
| Nov 27, 24 | KNSAKiniksa Pharmaceuticals International, plc | SELL | 8.6K | $22.45 | $194K |
| Mar 1, 24 | KNSAKiniksa Pharmaceuticals, Ltd. | SELL | 9.7K | $21.45 | $207K |
| Feb 28, 24 | KNSAKiniksa Pharmaceuticals, Ltd. | SELL | 5.1K | $21.79 | $112K |
| Jan 2, 24 | KNSAKiniksa Pharmaceuticals, Ltd. | SELL | 16.7K | $19.17 | $320K |
| Dec 19, 23 | KNSAKiniksa Pharmaceuticals, Ltd. | SELL | 9.3K | $19.13 | $178K |